Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome

Status Not yet recruiting

Clinical Trial Summary

Compare the efficacy and safety of endovascular treatment with sandwich technique (controlled release coils and 2% polidocanol foam) associated with diosmin-hisperidine and ibuprofen medical treatment and only the best chronic medical treatment available diosmin-hisperidine and ibuprofen for 3 months, in women of active gynecological age carrying pelvic congestion syndrome in public assistance in Montevideo, Uruguay.

Clinical Trial Description

Pelvic congestion syndrome (PCS) is a recognized and frequent cause of Chronic Pelvic Pain (10% to 30%). It is defined as the presence of chronic symptoms, which may include pelvic pain, perineal heaviness, urinary urgency and postcoital pain, caused by reflux and / or obstruction of the gonadic and / or pelvic veins, and that may be associated with vulvar, perineal and lower limbs varicose veins.

There is no standard approach to managing PCS. According to expert recommendations, therapies should be individualized according to the patient's symptoms and needs.

Medical treatment options include progestagens, danazol, combined oral hormonal contraceptives, phlebotonics such as hisperidine-added diosmin, non-steroidal anti-inflammatory drugs and gonadotropin-releasing hormone (GnRH) agonists

Currently, the only accepted chronic medical treatment is the association of non-steroidal and phlebotonic anti-inflammatories, but they have shown a poor symptomatic benefit in reducing pain.

Surgical treatment has evolved over time mainly in the hands of laparoscopic techniques, currently the endovascular option is the most widely accepted for presenting excellent long-term results with abolition of pain in up to 90% at 2 years.

HYPOTHESIS

Endovascular treatment of pelvic congestion syndrome is better in terms of pain control and quality of life compared to drug treatment.

General objective

Compare the efficacy and safety of endovascular treatment with sandwich technique (controlled release coils and 2% polidocanol foam) associated with diosmin-hisperidine and ibuprofen medical treatment and only the best chronic medical treatment available diosmin-hisperidine and ibuprofen for 3 months, in women of active gynecological age carrying pelvic congestion syndrome in public assistance in Montevideo, Uruguay.

Specific objectives

• Compare pain in patients undergoing endovascular treatment with the best

medical treatment.

- Evaluate the persistence of pelvic varices in patients undergoing endovascular treatment of SCP.

- Compare the Female Sexual Satisfaction Index in both groups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04358497
Study type	Interventional
Source	Hospital de Clínicas Dr. Manuel Quintela
Contact	Sebastian Sarutte, VS
Phone	+59899533449
Email	ssarutte1@hotmail.com
Status	Not yet recruiting
Phase	Phase 4
Start date	October 1, 2020
Completion date	October 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05633277` - Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections	N/A
Completed	`NCT04758728` - Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping	N/A
Recruiting	`NCT05409976` - The GORE® VIAFORT Vascular Stent IVC Study	N/A
Completed	`NCT06395025` - Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Comparison With a Control Group	N/A
Completed	`NCT03703765` - Volume Estimation of the Limb After VEnous Treatment	N/A
Completed	`NCT01368159` - Efficacy on Pain Following a Procedure for Injecting Sclerotherapeutic Foam Into the Great Saphenous Vein	Phase 4
Recruiting	`NCT05628948` - Vascular Lab Resource (VLR) Biorepository
Completed	`NCT06153680` - Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return	N/A
Terminated	`NCT03363633` - Perforator Vein Injection for Symptomatic Venous Disease	N/A
Recruiting	`NCT05489588` - The GORE® VIAFORT Vascular Stent Iliofemoral Study	N/A
Completed	`NCT02655887` - BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease	N/A
Recruiting	`NCT05050799` - US Post-Market Surveillance Study of the Surfacer System
Completed	`NCT01993914` - Prevalence of MTHFR Polymorphisms in Venous Disease	N/A
Active, not recruiting	`NCT04138134` - Autophagy and Venous Endothelial Function
Terminated	`NCT04964817` - HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease Study
Recruiting	`NCT02139085` - Great Saphenous Vein Electrocoagulation	Phase 2
Completed	`NCT01509599` - Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation	Phase 1/Phase 2
Terminated	`NCT03630185` - A Comparison of Custom-manufactured vs. Off-the-rack (OTR) Compression Hosiery for Initial Management of Venous Disease	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome — ENDPCS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms